Compound ID | 2687
Class: Natural product antibiotic
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against Staphylococcus aureus, Streptococcus sp., Escherichia coli, Proteus vulgaris, Pseudomonas sp., and Salmonella schottmuelleri |
| Description: | Natural product from Streptomyces ambofaciens; protects mice from Staphylococcus and Streptococcus infection when administered via intraperitoneal or subcutaneous route but not by oral route; contains a phosphoglycolipid scaffold |
| Institute where first reported: | Merck & Co., Inc., Rahway, N.J. |
| Year first mentioned: | 1974 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://patents.google.com/patent/US3891753A/en |
| Patent: | US3891753A |